LeapZipBlog: Dheeraj Shaha

Dheeraj Shaha's blog

10 blogs

Radiotherapy Market | Key Players, Segments, Business Analysis

June 26, 2019 by Dheeraj Shaha  

“The radiotherapy market is projected to grow at a CAGR of 4.1% during the forecast period”

The global radiotherapy market is projected to reach USD 6.8 billion by 2023 from USD 5.6 billion in 2018, at a CAGR of 4.1%. Growth in this market is largely driven by factors such as the growing global prevalence of cancer, increasing adoption of radiotherapy in clinical trials, and the increasing number of radiotherapy centers worldwide. However, the underdeveloped public health infrastructure in emerging countries, shortage of trained and skilled radiation oncologists, and the limited access to and affordability of various radiotherapy treatment options are the major factors that are expected to restrain the growth of this market during the forecast period.

“The linear accelerators segment is expected to account for the largest market share during the forecast period”

Based on product type, the external beam radiotherapy products market is segmented into linear accelerators (LINAC), particle therapy systems, and conventional cobalt-60 teletherapy units. The linear accelerators segment is expected to account for the largest share of this market in 2018, driven by the development of advanced systems and their growing adoption across the globe.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567

The seeds segment is expected to hold the largest share of the internal beam radiotherapy/brachytherapy products market during the forecast period”

Based on product type, the internal beam radiotherapy/brachytherapy products market is segmented into seeds, applicators, afterloaders, and electronic brachytherapy products. The seeds segment is expected to account for the largest share of this market in 2018. The large share of this segment can be attributed to the growing availability of seeds; advances in patient selection, treatment planning, technique, and technology; and growing applications in prostate cancer treatment.

Europe to account for the second-largest share of the global market in 2018

The radiotherapy market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. Europe is expected to account for the second-largest share of the global radiotherapy market in 2018. The growing incidence of cancer, supportive government initiatives, and the implementation of radiotherapy training programs & conferences/symposiums are the major factors propelling the demand for radiotherapy products in Europe. Furthermore, several key market players are focusing on enhancing their radiotherapy products to improve the quality of patient care across Europe.

Request Free Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=567

Medical Electrodes Market Insights | Growth Analysis

June 25, 2019 by Dheeraj Shaha  

“Medical electrodes market projected to grow at a CAGR of 4.7%”

The diagnostic medical electrodes market is expected to reach USD 732.4 million by 2022 from USD 583.2 million in 2017, at a CAGR of 4.7%. Growth in this market is mainly driven by the rising incidence and prevalence of neurological and cardiovascular disorders, increasing investments in medical device research, and growing preference for home and ambulatory healthcare. In addition, emerging markets such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the market.

“Disposable electrodes are expected to witness high growth during the forecast period”

Based on usability, the market is categorized as disposable and reusable electrodes. The disposable electrodes segment is expected to dominate this market. The large share and high growth of this segment can be attributed to the growing adoption of disposable electrodes due to advantages such as cost effectiveness and the low risk of cross contamination.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171260948

“ECG to dominate the medical electrodes market”

Based on diagnostic procedures, the market is segmented into the market is segmented into electrocardiography (ECG), electroencephalography (EEG), electromyography (EMG), and other procedures [electroretinography (ERG) and electrooculography (EOG)]. Among these, the ECG segment accounts for the largest share of the market. This can be attributed to the rising prevalence of CVD, increasing incidence of arrhythmias, and technological advancements in ECG electrodes.

“North America to dominate the market and Asia to witness high growth during the forecast period”

In 2017, North America is expected to account for the largest share of the market. Factors such as high prevalence of cardiac and neurological diseases and increasing product innovation in the region are driving the growth of the North American market. However, the Asian market is estimated to register the highest CAGR during the forecast period. Growth in the Asian market is primarily attributed to the rising prevalence of cardiac and neurological diseases, growth in aging population, rising adoption of advanced technologies, and the growing focus of major players on enhancing their presence in emerging Asian countries.

Adhesion Barrier Market worth $1,064 million by 2027

June 24, 2019 by Dheeraj Shaha  

Factors such as the rising geriatric population, increase in the volume of surgeries and sports-related injuries, and increasing awareness about the medical implications of adhesions are expected to drive market growth during the forecast period. The untapped emerging markets are expected to present growth opportunities for players in the adhesion barrier market.

The hyaluronic acid segment is projected to witness the highest growth during the forecast period

Based on the type, the synthetic adhesion barrier market is further classified into hyaluronic acid, regenerated cellulose, polyethylene glycol (PEG), and other synthetic adhesion barriers (such as combination products of polyethylene oxide and carboxymethylcellulose, icodextrin, silicone rubber, expanded polytetrafluorethylene (ePTFE) membrane, and hydrogel). The hyaluronic acid segment is expected to grow at the highest CAGR during the forecast period. Growth in this market is driven by the growing preference for hyaluronic acid-based adhesion barriers among surgeons.

The gel formulation is expected to grow at the highest CAGR during the forecast period

On the basis of formulations, the adhesion barrier market is segmented into film, liquid, and gel formulations. During the forecast period, the gel formulations segment is expected to grow at the highest CAGR. Growth in this segment is due to the growth in the demand and preference for gel-form adhesion barriers among end users.

The neurological surgeries segment is expected to register the highest CAGR during the forecast period

Based on applications, the adhesion barriers market is segmented into gynecological surgeries, general/abdominal surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, reconstructive surgeries, urological surgeries, and other surgeries (such as ear, nose, throat, and burn surgeries). The neurological surgeries segment is estimated to register the highest CAGR during the forecast period. The growth of this segment is driven by the increasing focus of players on developing adhesion barrier gels for neurological surgeries.

Know more:
https://www.marketsandmarkets.com/PressReleases/adhesion-barrier.asp

Immuno Oncology Assays Market | Growth, Industry Trends Insights

June 19, 2019 by Dheeraj Shaha  

The Asia Pacific is projected to record the highest growth rate in immuno oncology assays market. Factors such as growing number of CROs in the region, increasing awareness about early detection of cancer, and the shift of manufacturers’ and suppliers’ focus from developed economies to emerging economies, such as India and China are driving the growth of this regional segment.

Immuno Oncology Assays Market

Recent Developments:

1 In 2018, Roche collaborated with SQZ Biotech to develop antigen presenting cells-based immune-oncology treatments.

2 In 2018, Illumina launched its TruSight Oncology 500 assay, which is used to identify known and emerging tumor biomarkers.

3 In 2018, Roche acquired Tusk Therapeutics to expand its oncology product portfolio.

4 In 2018, Agilent acquired ACEA Biosciences (US). This acquisition will help both the companies to focus on real-time, live-cell analyzes through their expertise in cellular function and metabolism measurements.

5 In 2016, Thermo Fisher collaborated with Invivoscribe Technologies to develop NGS-based in vitro diagnostic oncology tests.

The market study covers the immuno oncology assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of product, technology, application, indication, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

The market for immuno-oncology assays is expected to reach USD 5.9 billion by 2024 from USD 2.9 billion in 2018, at a CAGR of 12.7%.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52562166

Moreover, the study showcases back-to-back parameters like application, improvement, product growth, and diverse structures & key processes. The report highlights the in-depth analysis of various critical parameters such as profit & loss statistics, product value, production capability, production process, and many more.

The Immuno Oncology Assays Market report delivers a perfect solution, which incorporates current market intelligence, future projections for the growth, technology inputs, and future market trends.

The report focuses on key strategic developments, analytical tools, and market feature. The report exhibits a top to the bottom estimate of the Immuno Oncology Assays Market which includes key patterns, key players, market drivers, challenges, arrangement patterns, openings, esteem chain, professional outlines, and future guide.

Key Market Players:

The key players operating in the immuno-oncology assays market are Thermo Fischer Scientific (US), Roche Diagnostics (Switzerland), Agilent Technologies (US), and Illumina (US). A majority of the leading players in the market focus on both organic and inorganic growth strategies such as collaborations, partnerships, acquisitions, and agreements to maintain and enhance their market shares in the immuno-oncology assays market.

Source:  https://listnewpress.wordpress.com/2019/06/14/immuno-oncology-assays-market-growth-industry-trends-insights/ ​​​​​​​

Interventional Oncology Market Industry Trends | Growth, Size, Share Analysis

June 18, 2019 by Dheeraj Shaha  

The interventional oncology market is segmented into five major regions, namely North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Europe accounted for the second-largest share in 2018. The rising incidence of cancer, coupled with the growing geriatric population in Europe, is a key factor propelling the demand for interventional oncology products in this region. Prominent market players are focusing on improving the quality of patient care across Europe by commercializing advanced products, investing in technological innovations, and partnering with other institutions and organizations for spreading cancer awareness.

interventional-oncology-market

This report studies the interventional oncology market based on products, procedure, cancer type, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting market growth. It also provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and the respective countries in these regions.

Growth in the interventional oncology market can be attributed to factors such as the rising preference for minimally invasive procedures, expansion of the target patient population, and increasing public-private funding and government support for cancer research. On the other hand, the dearth of well-trained and skilled radiologists and oncologists, high costs of interventional oncology procedures, and unfavorable regulations are expected to limit market growth to a certain extent.

This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the interventional oncology market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Moreover, the study showcases back-to-back parameters like application, improvement, product growth, and diverse structures & key processes. The report highlights the in-depth analysis of various critical parameters such as profit & loss statistics, product value, production capability, production process, and many more.

The Interventional Oncology Market report delivers a perfect solution, which incorporates current market intelligence, future projections for the growth, technology inputs, and future market trends.

The report focuses on key strategic developments, analytical tools, and market feature. The report exhibits a top to the bottom estimate of the Interventional Oncology Market which includes key patterns, key players, market drivers, challenges, arrangement patterns, openings, esteem chain, professional outlines, and future guide.

The interventional oncology market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 6.8%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164

The major players operating in the interventional oncology market include BTG plc (UK), Medtronic (Ireland), Boston Scientific (US), Terumo (Japan), Merit Medical (US), Sirtex (China), AngioDynamics (US), Ethicon (US), Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves (US), Sanarus (US), IMBiotechnologies (Canada), Trod Medical (US), IceCure Medical (Israel), Mermaid Medicals (Denmark), Interface Biomaterials BV (Netherlands), Guerbet (France), ABK Biomedical (Canada), Shape Memory Medical (US), Endo Shape (US), Monteris Medical (US), Instylla (US), and Trisalus Lifesciences (US).

This research study involved the extensive use of secondary sources, directories, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva), along with government databases, which were used to identify and collect information for this method-based, market-oriented, and commercial study of the interventional oncology market.

In-depth interviews were conducted with various primary respondents that mainly include key industry participants, medical practitioners, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify critical qualitative and quantitative information as well as to assess prospects of the interventional oncology market.

Interventional Oncology Market, by Product

  • Embolization Devices
  • Radioembolic Agents
  • Non-radioactive Embolic Agents
  • Ablation Devices
  • Radiofrequency Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Other Ablation Devices
  • Support Devices
  • Microcatheters
  • Guidewires

 

Interventional Oncology Market, by Procedure

  • Thermal Tumor Ablation
  • Non-thermal Tumor Ablation
  • Transcatheter Arterial Chemoembolization (TACE)
  • Transcatheter Arterial Radioembolization (TARE) or Selective Internal Radiation Therapy (SIRT)
  • Transcatheter Arterial Embolization (TAE) or Bland Embolization

 

Interventional oncology Market, by Cancer Type

  • Liver Cancer
  • Kidney Cancer
  • Lung Cancer
  • Bone Cancer
  • Other Cancers


Source:  https://listnewpress.wordpress.com/2019/06/17/interventional-oncology-market-growth-industry-insights/

Medical Terminology Software Market | Growth, Industry Trends

June 17, 2019 by Dheeraj Shaha  

The Asia Pacific market is projected to register the highest growth rate in medical terminology software market. Factors such as improving healthcare infrastructure, rising healthcare insurance coverage, and growing medical tourism in the region are driving the growth of the medical terminology software market in the Asia Pacific. Asian countries such as India, China, Malaysia, and Indonesia are in the early stages of adopting healthcare IT solutions including medical terminology solutions, while countries like Australia, New Zealand, and Singapore are at the forefront.

The report analyzes the various type of medical terminology software and their adoption patterns. It aims at estimating the market size and future growth potential of the global medical terminology software market for different segments such as application, product& service, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their presence in the market.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=239939409


This report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global medical terminology software market. The report analyzes the global medical terminology software market by application, product & service, end user, and region

Product Development/Innovation: Detailed insights on the upcoming trends and new product launches in the global medical terminology software market

Market Development: Comprehensive information on the lucrative emerging regions by application, product & service, and end user

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global medical terminology software market

Competitive Assessment: In-depth assessment of market ranking, growth strategies, and products of leading players in the global medical terminology software market

Read more: 
https://www.marketsandmarkets.com/PressReleases/medical-terminology-software.asp

Objectives of the Study

To define, describe, and forecast the medical terminology software market on the basis of product & service, application, end user, and region

To provide detailed information about factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)

To strategically analyze micromarketswith respect to individual growth trends, prospects, and contributions to the overall medical terminology software market

To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players

To forecast the size of the market segments with respect to five  main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

To strategically profile key players and comprehensively analyze their core competencies in the medical terminology software market

To track and analyze competitive developments such as partnerships, agreements, collaborations, alliances, mergers & acquisitions, product launches, expansions, and R&D activities in the medical terminology software market

The growth in this market is driven by factors such as the rising focus on minimizing medical errors, government initiatives for HCIT adoption, and disparity and fragmentation in the terminology content of healthcare organizations. The increasing need to maintain data integrity is expected to provide further growth opportunities for market players in the coming years.

Intelligent Medical Objects (US), Wolters Kluwer (Netherlands), and Clinical Architecture (US) are the major players in this market. These companies mainly focus on product launches, partnerships, and collaborations to strengthen their presence in the medical terminology software market.

Know more about key strategies adopted by industry players:
https://www.marketsandmarkets.com/ResearchInsight/medical-terminology-software-market.asp

Moreover, the study showcases back-to-back parameters like application, improvement, product growth, and diverse structures & key processes. The report highlights the in-depth analysis of various critical parameters such as profit & loss statistics, product value, production capability, production process, and many more.

The Medical Terminology Software Market report delivers a perfect solution, which incorporates current market intelligence, future projections for the growth, technology inputs, and future market trends.

The report focuses on key strategic developments, analytical tools, and market feature. The report exhibits a top to the bottom estimate of the Medical Terminology Software Market which includes key patterns, key players, market drivers, challenges, arrangement patterns, openings, esteem chain, professional outlines, and future guide.

 


Temperature Monitoring Systems Market | Growth, Size, Industry Trends

June 14, 2019 by Dheeraj Shaha  

The temperature monitoring systems market in the Asia Pacific is expected to witness the highest CAGR from 2019 to 2024. Factors such the growing food safety concerns, increasing R&D activities, rising government healthcare expenditure, the presence of stringent regulatory policies for food & drug safety, and the growth of the biotechnology and pharmaceutical industries in key APAC countries such as India and China are the major factors driving the growth of this regional segment.

This report studies the
temperature monitoring systems market based on type, end user, application, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four major regions.

The global temperature monitoring systems market is projected to reach USD 5.4 billion by 2024 from USD 4.5 billion in 2019, at a CAGR of 3.9%

Read more: 
https://www.marketsandmarkets.com/PressReleases/temperature-monitoring-system.asp

Moreover, the study showcases back-to-back parameters like application, improvement, product growth, and diverse structures & key processes. The report highlights the in-depth analysis of various critical parameters such as profit & loss statistics, product value, production capability, production process, and many more.

The Temperature Monitoring Systems Market report delivers a perfect solution, which incorporates current market intelligence, future projections for the growth, technology inputs, and future market trends.

The report focuses on key strategic developments, analytical tools, and market feature. The report exhibits a top to the bottom estimate of the Temperature Monitoring Systems Market which includes key patterns, key players, market drivers, challenges, arrangement patterns, openings, esteem chain, professional outlines, and future guide.

Several companies such as 3M (US), Abb Ltd. (Switzerland), Deltatrack (US), Emerson Electric (US), Fluke Corporation (subsidiary of Fortive Corporation) (US), Honeywell (US), Kelsius, Ltd. (Ireland), Monnit Corporation (US), Omega Engineering (US), Rees Scientific (US), and SensoScientific, Inc. are investing in high-growth markets to gain significant profits and increase their share in the global temperature monitoring systems market.

Know more about key strategies adopted by industry players:
https://www.marketsandmarkets.com/ResearchInsight/temperature-monitoring-system-market.asp

Digital Diabetes Management Market | Insights, Growth, Size Analysis

June 13, 2019 by Dheeraj Shaha  

The global digital diabetes management market in North America is expected to grow at the highest CAGR during the forecast period. This is due to the growing demand for technologically advanced solutions such as closed-loop systems, high adoption of remote online coaching services for diabetes management, high adoption of connected diabetes management devices and apps, favorable reimbursement policies, increased acceptance of digital diabetes solutions from payers, rising awareness on self-diabetes management and government initiatives to promote digital health in the region.

The growth of digital diabetes management market is mainly driven by the rising prevalence of diabetes, increasing focus on the development and adoption of digital platform for diabetes, and technological advancements.

The growing demand for wireless and wearable devices for diabetes management, growing acceptance of smart insulin pumps & pens for insulin delivery, technological innovations & digital advancements in devices, and increasing awareness about continuous glucose monitoring in patients are the key factors driving the growth of the devices segment.

Read more:  https://www.marketsandmarkets.com/PressReleases/digital-diabetes-management.asp

Prominent players in the global digital diabetes management market are Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel).

These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, approvals, and enhancements; expansions; agreements, collaborations, and partnerships; and mergers & acquisitions.

Know more about key strategies adopted by industry players:
https://www.marketsandmarkets.com/ResearchInsight/digital-diabetes-management-market.asp

Vascular Patches Market Insights | Trends, Growth Analysis

June 12, 2019 by Dheeraj Shaha  

Factors such as rapidly growing geriatric population and the subsequent increase in the prevalence of vascular diseases; increasing number of vascular surgeries performed; and increasing adoption of biological patches are driving the growth of the vascular patches market. The decreasing number of carotid endarterectomy surgeries and product failures and recalls are expected to limit market growth in the coming years. 

The key players in the vascular patches market include Terumo Corporation (Japan), C. R. Bard, Inc. (US), B. Braun Melsungen AG (Germany), LeMaitre Vascular, Inc. (US), Maquet (Germany), W. L. Gore & Associates, Inc. (US), Admedus (Australia), CryoLife, Inc. (US), Labcor Laboratórios Ltda (Brazil), Baxter International Inc. (US), and Edwards Lifesciences Corporation (US).

The vascular patches market is expected to reach USD 525.8 million by 2023 from USD 349.6 million in 2018, at a CAGR of 8.5%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=176813375


The report analyses the vascular patches market by material, application, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful.

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use one or a combination of the below mentioned five strategies for strengthening their market shares.


Read Press Release On Vascular Patches Market:
https://www.marketsandmarkets.com/PressReleases/vascular-patches.asp

Asia Pacific is estimated to grow at the fastest rate due to the rising prevalence of cardiovascular diseases and the implementation of favorable government initiatives in several Asian countries. In India, for example, the central government and the Health Ministry launched the AMRIT (Affordable Medicines & Reliable Implants for Treatment) program in 2015, which enables pharmacies in government hospitals to sell various devices, cardiac implants, and cardiovascular drugs at 50–60% lower prices. Such initiatives will help boost the demand for cardiac products, including vascular patches, in the coming years.

Biosimulation Market Insights, Trends | Global Industry Report

June 11, 2019 by Dheeraj Shaha  

Factors such as increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets are driving the growth of the market.

 

The biosimulation market is highly competitive with the presence of various players. Some of the major players operating in the market are Certara (US), Simulation Plus (US), Dassault Systèmes (France), Schrödinger (US), ACD/Labs (Canada), Chemical Computing Group (Canada), Physiomics (UK), Evidera (US), In silico biosciences (US), INOSIM Software (Germany), Insilico Biotechnology (Germany), LeadInvent Technologies (India), Rosa (US), Nuventra Pharma (US), and Genedata (Switzerland).
The biosimulation market is expected to reach USD 2.88 Billion by 2022 from USD 1.20 Billion in 2016 growing at a CAGR of 15.9%

Product launches & upgradations accounted for the largest share of the overall growth strategies followed by key players between 2014 and 2017. Some of the companies that adopted this strategy include Certara, Simulation Plus, Schrödinger, ACD/Labs, and Chemical Computing Group.
Certara is one of the leading players in the biosimulation market. This leading position of the company can be attributed to its strong brand recognition and extensive product portfolio in the market. The company has a vast presence in North America, Europe, Asia, and Australia. In order to maintain its leading position in the biosimulation market the company focuses on inorganic and organic growth strategies like product launches and upgradations, expansions, acquisitions, and partnerships. For instance, in September 2016, the company acquired d3 Medicine (Australia) to enhance the company’s expertise in the field of modeling and simulation modeling, simulation, and regulatory science powerhouse. Likewise, in October 2017, the company launched Phoenix 8.0 PK/PD Modeling and Simulation software.
Read Press Release On Biosimulation Market Insights:
https://www.marketsandmarkets.com/PressReleases/biosimulation.asp
 

 

The report provides insights on the following:

1 Product Development: Product portfolios of the top players in the biosimulation market.
2 Competitive Assessment: In-depth assessment of the business segments and product portfolios of the leading players in the biosimulation market.
3 Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various biosimulation products and services across geographies.